Andrew Dahlinghaus

Vice President, Chief Compliance Officer

ANDREW B. DAHLINGHAUS is Vice President & Chief Compliance Officer at ConvaTec Group PLC, a newly-listed U.K. medical products and technologies company with approximately 9000 employees doing business in over 100 countries.  Prior to joining ConvaTec, Andrew served in various leadership roles in Covidien’s Legal & Compliance Department and then within Medtronic’s Compliance Department subsequent to Medtronic’s acquisition of Covidien.  During his tenure at Covidien/Medtronic, Andrew had global responsibility for driving compliance, developing and implementing most aspects of Covidien’s global program.  Before transitioning to an in-house role, Andrew was an attorney in the Washington, DC office of Arent Fox, LLP, where he counseled medical device and pharmaceutical manufacturers and providers on matters involving the federal Anti-Kickback Statute, the federal Food, Drug & Cosmetic Act and the False Claims Act.  Andrew has implemented compliance programs at numerous entities and defended providers and manufacturers in government investigations involving alleged violations of federal fraud and abuse laws.  Andrew is a graduate of the George Washington University Law School.